Opiant Pharmaceuticals Inc - Company & Market Research Reports

Opiant Pharmaceuticals is a specialty pharmaceutical company that develops opioid antagonist treatments for addictions and related disorders. The company’s portfolio includes NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa. Formerly known as Lightlake Therapeutics, it changed its name in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

CNS Cluster Addiction Drug Development Pipeline Review, 2017 - Product Thumbnail Image

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Global Substance Abuse Treatment Market 2017-2021 - Product Thumbnail Image

Global Substance Abuse Treatment Market 2017-2021

  • Report
  • 73 Pages
From
Opioid Receptor Antagonists- Pipeline Insight, 2018 - Product Thumbnail Image

Opioid Receptor Antagonists- Pipeline Insight, 2018

  • Drug Pipelines
  • 99 Pages
From
Opium (Opioid) Addiction - Pipeline Review, H2 2018 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H2 2018

  • Drug Pipelines
  • 121 Pages
From
Drug Overdose - Pipeline Review, H2 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H2 2018

  • Drug Pipelines
  • 65 Pages
From
Alcohol Addiction - Pipeline Review, H2 2018 - Product Thumbnail Image

Alcohol Addiction - Pipeline Review, H2 2018

  • Drug Pipelines
  • 151 Pages
From
Opium (Opioid) Addiction - Pipeline Review, H1 2018 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H1 2018

  • Drug Pipelines
  • 109 Pages
From
Drug Overdose - Pipeline Review, H1 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H1 2018

  • Drug Pipelines
  • 57 Pages
From
Transmucosal Drug Delivery - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Transmucosal Drug Delivery - Medical Devices Pipeline Assessment, 2018

  • Report
  • 194 Pages
From
Intranasal Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Intranasal Drug Delivery - Global Strategic Business Report

  • Report
  • 239 Pages
From
Bioavailability Enhancement Technologies and Services Market, 2018-2030 - Product Thumbnail Image

Bioavailability Enhancement Technologies and Services Market, 2018-2030

  • Report
  • 300 Pages
From
Binge Eating Disorder - Pipeline Review, H2 2018 - Product Thumbnail Image

Binge Eating Disorder - Pipeline Review, H2 2018

  • Drug Pipelines
  • 50 Pages
From
Bulimia Nervosa Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Bulimia Nervosa Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 46 Pages
From
Pathological Gambling Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pathological Gambling Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 42 Pages
From
Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 45 Pages
From
Opiant Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Opiant Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Opiant Pharmaceuticals Inc - Product Thumbnail Image

Opiant Pharmaceuticals Inc

  • Company Profile
  • 69 Pages
Opiant Pharmaceuticals Inc Strategic Analysis Review - Opiant Pharmaceuticals Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Opiant Pharmaceuticals Inc Strategic Analysis Review - Opiant Pharmaceuticals Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Opiant , Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Opiant , Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 19 Results (Page 1 of 1)
Loading Indicator
adroll